Who Paid My Doc
Clinton Wilkinson
Critical Care Medicine Charlottesville, VA Medical Doctor
NPI 1326609058 CMS profile 7222745
1215 Lee St, Charlottesville, VA 22908
General payments
$8,917
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Clinton Wilkinson of Charlottesville, VA is reported in the CMS Open Payments database as having received $8,917 across 119 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,714 | 38 | |
| 2024 | General | $4,219 | 56 | |
| 2023 | General | $2,984 | 25 |
Beside peers
- Clinton Wilkinson
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Clinton Wilkinson were reported at $1,714. Among 445 Critical Care Medicine profiles paid that year, the median was $97 and the middle half received between $33 and $255.
Show as a table
| Year | Clinton Wilkinson | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $103 | $29–$256 | $163 |
| 2020 | $0 | $60 | $22–$164 | $114 |
| 2021 | $0 | $115 | $30–$249 | $132 |
| 2022 | $0 | $97 | $27–$196 | $149 |
| 2023 | $2,984 | $104 | $31–$245 | $160 |
| 2024 | $4,219 | $93 | $28–$268 | $164 |
| 2025 | $1,714 | $97 | $33–$255 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 23 drugsPart D claims
1,282
Drug cost
$38,973
Branded share of claims
28.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Buprenorphine | Generic | 47 | $10,589 | |
| Belbuca Buprenorphine Hcl | Brand | 15 | $8,751 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 139 | $3,260 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 181 | $2,893 | |
| Pregabalin | Generic | 126 | $2,844 | |
| Gabapentin | Generic | 148 | $1,799 | |
| Diclofenac Sodium | Generic | 22 | $1,562 | |
| Tramadol Hcl Er Tramadol Hcl | Brand | 21 | $1,128 | |
| Tizanidine Hcl | Generic | 87 | $1,101 | |
| Baclofen | Generic | 82 | $989 |
The 10 drugs with the highest cost, of 23 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 48 billing codesPaid by Medicare
$68,222
Medicare patients
257
Services billed
773
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 42% | |
| Depression | 31% | |
| Chronic kidney disease | 30% | |
| Ischemic heart disease | 26% | |
| COPD | 23% | |
| Atrial fibrillation | 19% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
119 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in Virginia
Robert Thiele
Critical Care Medicine · Charlottesville, VA
Lewis Pasternak
Critical Care Medicine · Mc Lean, VA
Michael Mazzeffi
Critical Care Medicine · Charlottesville, VA
Matthew Hulse
Critical Care Medicine · Charlottesville, VA
Danny Theodore
Critical Care Medicine · Charlottesville, VA
David Stombaugh
Critical Care Medicine · Charlottesville, VA
Related records
Critical Care Medicine in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.